Answers are grounded in this paper and cite their sources.
Studies were performed on the capacity of mice for hemagglutinating antibody production throughout their life-span. An in vivo culture method was used for assessment of primary and secondary antibody-forming potentials of spleen cells of mice ranging in age from 1 to 130 weeks. There was a marked growth of potential for antibody formation during neonatal and juvenile life followed by a gradual decline in potential with advancing age. It was possible to show that the changes in potential were principally due to changes in the number of competent progenitor cells and not to changes in their performance. Death of very old animals was correlated with decline in number of immunologically competent progenitor cells. The decay in number of progenitor cells during aging of mice was random. Loss of progenitor cells was not entirely attributable to either generative failure of the pool of progenitor cells or the capacity of the milieu of the animal to support such cells. Thus, spleen cells from aged animals displayed increasing capacity for primary antibody formation during a 3-week period of culture in young, irradiated mice; identical cultures in old, irradiated recipients failed in respect to growth of primary antibody-forming potential. Progressive imparirment of the milieu of aging animals was suggested by the fact that spleen cells from very old animals were “toxic” when infused into lightly irradiated recipients which were themselves of advanced age but far short of the senescent phase of their life-span. These results lead to the argument that senescence may be, to a major degree, the result of progressive loss of progenitor, or “stem,” cells which are normally utilized to replace terminally differentiated, dying cells.
No takes yet. Share an insight, caveat, or question.
Albright et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: